No evidence for an acute placebo effect on emotional processing in healthy volunteers

Abstract

Placebo-controlled trials are the gold standard measure of efficacy in the development of new treatments for depression. However, the large placebo effects associated with standard measures of subjective symptoms reduce the sensitivity of such trials to detect antidepressant effects. There is a need to develop novel efficacy markers that are resistant to placebo effects. Measures of emotional processing, known to be sensitive to antidepressant treatment, may be such a marker, although the effect of an acute placebo treatment on these measures remains unclear. We assessed the influence of placebo on a validated battery of emotional processing tasks, the Emotional Test Battery (ETB), in healthy participants. Participants were informed they might receive the antidepressant drug bupropion, placebo or no treatment, with placebo effect being estimated as the difference between the placebo and no treatment groups. We found no significant difference between these groups on measures of emotional processing. There was also no effect of subjective treatment expectancy on performance in the tasks. This suggests that the ETB might be a useful tool for Phase I trials assessing novel antidepressant agents against placebo.

Keywords

Placebo placebo effect placebo response depression emotional processing

Get full access to this article

View all access options for this article.

References

Baldwin

Broich

Fritze

et al . (2003) Placebo-controlled studies in depression: Necessary, ethical and feasible. Eur Arch Psychiatry Clin Neurosci 253: 22–28.

Benedetti

Carlino

Pollo

(2011) How placebos change the patient’s brain. Neuropsychopharmacology 36: 339–354.

Browning

Reid

Cowen

et al . (2007) A single dose of citalopram increases fear recognition in healthy subjects. J Psychopharmacol (Oxford, England) 21: 684–690.

Clark

Watson

(1991) Tripartite model of anxiety and depression: Psychometric evidence and taxonomic implications. J Abnorm Psychol 100: 316–336.

Cooper

Langton

(2006) Attentional bias to angry faces using the dot-probe task? It depends when you look for it. Behav Res Ther 44: 1321–1329.

de la Fuente-fernández

Stoessl

(2002) The biochemical bases for reward: Implications for the placebo effect. Eval Health Prof 25: 387–398.

Ekman

Friesen

(1976) Pictures of Facial Affect. Palo Alto, CA: Consulting Psychologists Press.

Eysenck

Barrett

(1985) A revised version of the psychoticism scale. Pers Individ Dif 6: 21–29.

Faul

Erdfelder

Buchner

et al . (2009) Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behav Res Methods 41: 1149–1160.

10.

First

Spitzer

Gibbon

et al . (2002) Structured clinical interview for DSM-IV-TR axis I disorders, research version, non-patient edition. New York, NY: Biometrics Research, New York State Psychiatric Institute.

11.

Frewen

Dozois

Joanisse

et al . (2008) Selective attention to threat versus reward: Meta-analysis and neural-network modeling of the dot-probe task. Clin Psychol Rev 28: 307–337.

12.

Hamilton

(1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56–62.

13.

Harmer

Bhagwagar

Perrett

et al . (2003a) Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology 28: 148–152.

14.

Harmer

Goodwin

Cowen

(2009) Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. Br J Psychiatry 195: 102–108.

15.

Harmer

Hill

Taylor

et al . (2003b) Toward a neuropsychological theory of antidepressant drug action: Increase in positive emotional bias after potentiation of norepinephrine activity. Am J Psychiatry 160: 990–992.

16.

Harmer

Shelley

Cowen

et al . (2004) Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry 161: 1256–1263.

17.

Huneke

Baldwin

(2015) Does previous experience of antidepressants form the expectations necessary for a placebo response? Br J Psychiatry 207: 561.

18.

Jefferson

Pradko

Muir

(2005) Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations. Clin Ther 27: 1685–1695.

19.

Kass

Raftery

(1995) Bayes factors. J Am Stat Assoc 90: 773–795.

20.

Keedwell

Andrew

Williams

SCR

et al . (2005) The neural correlates of anhedonia in major depressive disorder. Biol Psychiatry 58: 843–853.

21.

Kessner

Forkmann

Ritter

et al . (2014) The effect of treatment history on therapeutic outcome: Psychological and neurobiological underpinnings. PloS One 9: e109014.

22.

Lidstone

Schulzer

Dinelle

et al . (2010) Effects of expectation on placebo-induced dopamine release in Parkinson disease. Arch Gen Psychiatry 67: 857–865.

23.

Meyer

Yuen

Ertl

et al . (2015) Neural mechanisms of placebo anxiolysis. J Neurosci 35: 7365–7373.

24.

Murphy

Norbury

O’Sullivan

et al . (2009) Effect of a single dose of citalopram on amygdala response to emotional faces. Br J Psychiatry 194: 535–540.

25.

Nelson

(1982) National Adult Reading Test (NART): For the Assessment of Premorbid Intelligence in Patients with Dementia: Test Manual. NFER-Nelson.

26.

Petrovic

Dietrich

Fransson

et al . (2005) Placebo in emotional processing–induced expectations of anxiety relief activate a generalized modulatory network. Neuron 46: 957–969.

27.

Rief

Nestoriuc

Weiss

et al . (2009) Meta-analysis of the placebo response in antidepressant trials. J Affect Disord 118: 1–8.

28.

Roiser

Elliott

Sahakian

(2012) Cognitive mechanisms of treatment in depression. Neuropsychopharmacology 37: 117–136.

29.

Rutchick

Slepian

(2013) Handling Ibuprofen increases pain tolerance and decreases perceived pain intensity in a cold pressor test. PloS One 8: e56175.

30.

Sibbald

Roland

(1998) Understanding controlled trials: Why are randomised controlled trials important? BMJ 316: 201.

31.

Snaith

Hamilton

Morley

et al . (1995) A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. Br J Psychiatry 167: 99–103.

32.

Von Zerssen

Strian

Schwarz

(1974) Evaluation of depressive states, especially in longitudinal studies. In: Pichot

Olivier-Martin

(eds.) Psychological Measurements in Psychopharmacology. Basel: Karger.

33.

Watson

(1988) Intraindividual and interindividual analyses of positive and negative affect: Their relation to health complaints, perceived stress, and daily activities. J Pers Soc Psychol 54: 1020–1030.

34.

Young

Rowland

Calder

et al . (1997) Facial expression megamix: Tests of dimensional and category accounts of emotion recognition. Cognition 63: 271–313.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.19 MB